Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for IMATINIB

Ingredient

IMATINIB

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
APO-IMATINIB	100MG	TABLET	Resolved	2022-04-08	2022-06-02	158358
APO-IMATINIB	100MG	TABLET	Resolved	2024-11-14	2025-01-17	243083
APO-IMATINIB	400MG	TABLET	Resolved	2017-07-31	2017-09-06	17609
APO-IMATINIB	400MG	TABLET	Resolved	2017-11-28	2018-04-18	31010
APO-IMATINIB	400MG	TABLET	Resolved	2018-07-31	2018-11-15	56986
APO-IMATINIB	400MG	TABLET	Resolved	2018-11-30	2019-01-10	68221
APO-IMATINIB	400MG	TABLET	Resolved	2021-04-16	2021-05-17	137578
IMATINIB	400MG	TABLET	Resolved	2024-04-19	2025-11-04	225714
IMATINIB	100MG	TABLET	Resolved	2024-04-19	2025-11-04	225711
JAMP IMATINIB	400MG	TABLET	Resolved	2024-02-08	2025-08-01	218844

Showing 11 to 20 of 39

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
PMS-IMATINIB	100MG	TABLET	Discontinued	2020-06-15	2021-10-27	117927
PMS-IMATINIB	400MG	TABLET	Discontinued	2020-06-15	2021-10-27	117930

1

Showing 1 to 2 of 2